Prasugrel effectively reduces the platelet reactivity units in patients with genetically metabolic dysfunction of cytochrome P450 2C19 who are treated with long-term dual antiplatelet therapy after undergoing drug-eluting stent implantation
Shimamatsu, Junichiro, Sasaki, Ken-ichiro, Katsuki, Yoshio, Kawasaki, Tomohiro, Murasato, Yoshinobu, Ajisaka, Hidehiko, Yokoi, Hiroyoshi, Tashiro, Hideki, Harada, Atsushi, Hirakawa, Yuji, Ishizaki, YuJournal:
Heart and Vessels
DOI:
10.1007/s00380-019-01499-7
Date:
September, 2019
File:
PDF, 726 KB
2019